Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1113 | 964 | 1126 | 1293 | 1495 | 2260 |
Fund Return | 11.27% | -3.59% | 12.58% | 8.94% | 8.37% | 8.49% |
Place in category | 1209 | 1886 | 1153 | 846 | 718 | 395 |
% in Category | 57 | 90 | 55 | 49 | 47 | 40 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LansfOrsakringar Global Indexnara | 128.68B | 33.31 | 15.72 | 14.41 | ||
Lansforsakringar USA Indexnara | 52.03B | 41.52 | 19.01 | 17.59 | ||
Lansforsakringar Sverige Indexnara | 36.23B | 9.89 | 1.26 | 9.17 | ||
Lansforsakringar Global Hallbar A | 25.69B | 33.18 | 13.38 | 12.82 | ||
Lansforsakringar Global Hallbar B | 25.69B | 33.55 | 13.71 | 13.09 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
SPP Aktiefond Europa | 18.07B | 15.05 | 10.88 | 9.08 | ||
Swedbank Robur Access Europa | 14.51B | 14.08 | 10.61 | 9.01 | ||
Handelsbanken Europafond Index | 13.02B | 12.51 | 9.21 | 8.73 | ||
Handelsbanken European Index utd | 13.02B | 12.51 | 9.22 | 8.25 | ||
AMF Aktiefond Europa | 8.14B | 9.40 | 8.32 | 8.73 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 4.07 | 589.2 | -20.72% | |
ASML Holding | NL0010273215 | 3.28 | 686.10 | -0.68% | |
SAP | DE0007164600 | 2.92 | 236.750 | -0.13% | |
Nestle | CH0038863350 | 2.68 | 73.98 | -0.30% | |
AstraZeneca | GB0009895292 | 2.46 | 10,256.0 | +0.12% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review